Author

Ehsan Nazemalhosseini Mojarad

Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical - Cited by 3,404 - Medical Biology - Immunology of Gastrointestinal cancer - Microbiota

Biography

Dr Ehsan Nazemalhosseini Mojarad is a Research Fellow and Lab manager of a research lab in the cancer department at the Research Institute for Gastroenterology and Liver Diseases. He is also Managing Director and Lead Auditor at RIGLD. His expertise is within molecular biology. He also has experience in Cancer biology especially in colorectal cancer achieving tangible results and meeting aggressive timelines.
Title
Cited by
Year
Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
R Sharma, M Abbasi-Kangevari, R Abd-Rabu, H Abidi, E Abu-Gharbieh, ...The Lancet Gastroenterology & Hepatology, 2022202
98
2022
Circular RNA hsa_circ_0005046 and hsa_circ_0001791 may become diagnostic biomarkers for breast cancer early detection
M Ameli-Mojarad, M Ameli-Mojarad, M Nourbakhsh, ...Journal of oncology 2021, 1-7, 2021202
22
2021
Fecal microbiota transplantation for COVID-19; a potential emerging treatment strategy
SA Nejadghaderi, E Nazemalhosseini-Mojarad, HA AghdaeiMedical hypotheses 147, 110476, 202
21
2021
Insights into the role of matrix metalloproteinases in precancerous conditions and in colorectal cancer
Z Pezeshkian, S Nobili, N Peyravian, B Shojaee, H Nazari, H Soleimani, ...Cancers 13 (24), 6226, 2021202
19
2021
The effective function of circular RNA in colorectal cancer
M Ameli-Mojarad, M Ameli-Mojarad, M Hadizadeh, C Young, H Babini, ...Cancer Cell International 21, 1-16, 2021202
13
2021
piRNA: a promising biomarker in early detection of gastrointestinal cancer
MA Mojarad, MA Mojarad, B Shojaee, E Nazemalhosseini-MojaradPathology-Research and Practice, 153757, 2022202
10
2022
Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-19 subjects
Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-1 subjectsS Abdolahi, M Hosseini, R Rezaei, SR Mohebbi, M Rostami-Nejad, ...Infection, Genetics and evolution 8, 105207, 2022202
9
2022
Toward finding the difference between untreated celiac disease and COVID-19 infected patients in terms of CD4, CD25 (IL-2 Rα), FOXP3 and IL-6 expressions as genes affecting …
Toward finding the difference between untreated celiac disease and COVID-1 infected patients in terms of CD4, CD25 (IL-2 Rα), FOXP3 and IL-6 expressions as genes affecting …N Asri, E Nazemalhosseini Mojarad, H Mirjalali, SR Mohebbi, K Baghaei, ...BMC gastroenterology 21, 1-8, 2021202
9
2021
Novel long noncoding RNAs upregulation may have synergistic effects on the CYP24A1 and PFDN4 biomarker role in human colorectal cancer
H Sadeghi, E Nazemalhosseini‐Mojarad, U Sahebi, E Fazeli, ...Journal of Cellular Physiology 236 (3), 2051-2057, 2021202
8
2021
Can hypoxia-inducible factor-1α overexpression discriminate human colorectal cancers with different microsatellite instability?
Z Arabsorkhi, H Sadeghi, E Gharib, L Rejali, H Asadzadeh-Aghdaei, ...Genes & Genetic Systems 9 (4), 193-198, 2021202
6
2021
Association between rs11614913 polymorphism of the MiR-196-a2 gene and colorectal cancer in the presence of departure from hardy-weinberg equilibrium
AR Soltanian, B Hosseini, H Mahjub, F Bahreini, NM Ehsan, ME GhaffariCell Journal (Yakhteh) 23 (3), 313, 2021202
5
2021
Increased Expression of VANGL1 Is Predictive of Lymph Node Metastasis in Colorectal Cancer: Results from a 20-Gene Expression Signature
N Peyravian, S Nobili, Z Pezeshkian, M Olfatifar, A Moradi, K Baghaei, ...Journal of Personalized Medicine 11 (2), 126, 2021202
5
2021
DNA Methylation Biomarkers in Colorectal Cancer: Clinical Applications for Precision Medicine
MT Nayeralsadat Fatemi,Sascha Tierling,Hamidreza Aboulkheyr Es,Maryam ...International Journal of Cancer, 2022202
5
2022
The association of clinicopathological characterizations of colorectal cancer with membrane-bound mucins genes and LncRNAs
H Iranmanesh, M Entezari, L Rejali, E Nazemalhosseini-Mojarad, ...Pathology-Research and Practice 233, 153883, 2022202
4
2022
Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy
F Ghorbani Parsa, S Nobili, M Karimpour, H Asadzadeh Aghdaei, ...J. Pers. Med. 12 (96), 2022202
3
2022
A linkage between effectual genes in progression of CRC through canonical and non‑canonical TGF‑β signaling pathways
NME Shirin M, Madadi S, Peyravian N, Pezeshkian Z, Rejali L, Hosseini M ...Medical Oncology 39 (40), 1-13, 20222202
2
2022
Autophagy ATG16L1 rs2241880 impacts the colorectal cancer risk: A case‐control study
Autophagy ATG16L1 rs41880 impacts the colorectal cancer risk: A case‐control studyL Jamali, H Sadeghi, MR Ghasemi, R Mohseni, ...Journal of clinical laboratory analysis, e4169, 0
2
2022
Oncogenic role of connective tissue growth factor is associated with canonical TGF-β cascade in colorectal cancer
S Hosseini, L Rejali, Z Pezeshkian, M Malekian, N Fatemi, N Peyravian, ...Genes 13 (4), 689, 0
2
2022
Correlated downregulation of VDR and CYP3A4 in colorectal cancer
H Sadeghi, V Hashemnia, E Nazemalhosseini-Mojarad, MR Ghasemi, ...Molecular biology reports 50 (), 1385-1391, 030
2
2023